Advances in understanding the genetic basis of diabetic kidney disease

被引:0
|
作者
Man Li
Marcus G. Pezzolesi
机构
[1] University of Utah School of Medicine,Division of Nephrology and Hypertension, Department of Internal Medicine,
[2] VA Cooperative Studies Program,VA Boston Healthcare System
[3] University of Utah School of Medicine,Diabetes and Metabolism Center
[4] University of Utah School of Medicine,Department of Human Genetics
来源
Acta Diabetologica | 2018年 / 55卷
关键词
Diabetic kidney disease; Diabetic nephropathy; Genetics; Genome-wide association study;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetic kidney disease (DKD) is a devastating complication of Type 1 and Type 2 diabetes and leads to increased morbidity and mortality. Earlier work in families has provided strong evidence that heredity is a major determinant of DKD. Previous linkage analyses and candidate gene studies have identified potential DKD genes; however, such approaches have largely been unsuccessful. Genome-wide association studies (GWAS) have made significant contribution in identifying SNPs associated with common complex diseases. Thanks to advanced technology, new analytical approaches, and international research collaborations, many DKD GWASs have reported unique genes, highlighted novel biological pathways and suggested new disease mechanisms. This review summarizes the current state of GWAS technology; findings from GWASs of DKD and its related traits conducted over the past 15 years and discuss the future of this field.
引用
收藏
页码:1093 / 1104
页数:11
相关论文
共 50 条
  • [31] The genetic basis of kidney cancer: a metabolic disease
    W. Marston Linehan
    Ramaprasad Srinivasan
    Laura S. Schmidt
    Nature Reviews Urology, 2010, 7 : 277 - 285
  • [32] The genetic basis of kidney cancer: a metabolic disease
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    Schmidt, Laura S.
    NATURE REVIEWS UROLOGY, 2010, 7 (05) : 277 - 285
  • [33] The genetic basis of kidney cancer: A metabolic disease
    Linehan, W. Marston
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [34] Recent advances in drug discovery for diabetic kidney disease
    Danta, Chhanda Charan
    Boa, Andrew N.
    Bhandari, Sunil
    Sathyapalan, Thozhukat
    Xu, Shang-Zhong
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (04) : 447 - 461
  • [35] Recent advances in the pharmacotherapeutic management of diabetic kidney disease
    Block, Tomasz J.
    Batu, Duygu
    Cooper, Mark E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (07) : 791 - 803
  • [36] Beyond APOL1: Genetic Inroads into Understanding Population Disparities in Diabetic Kidney Disease
    Skorecki, Karl
    Wasser, Walter G.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (06): : 928 - 931
  • [37] The genetic side of diabetic kidney disease: a review
    Song, Jinfang
    Ni, Jiang
    Yin, Xiaoxing
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (02) : 335 - 343
  • [38] Genetic and Epigenetic Studies in Diabetic Kidney Disease
    Gu, Harvest F.
    FRONTIERS IN GENETICS, 2019, 10
  • [39] Genetic Contribution to Risk for Diabetic Kidney Disease
    Rich, Stephen S.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (08): : 1135 - 1137
  • [40] Novel Genetic Determinants of Diabetic Kidney Disease
    Todd, Jennifer N.
    Salem, Rany
    Sandholm, Niina
    Valo, Erkka A.
    Hiraki, Linda T.
    Di Liao, Chen
    Pezzolesi, Marcus G.
    Smiles, Adam
    Onengut-Gumuscu, Suna
    Chen, Wei Min
    Mcgurnaghan, Stuart
    Mckeigue, Paul
    Mcknight, Amy J.
    Maxwell, Alexander P.
    Colhoun, Helen M.
    Krolewski, Andrzej S.
    Paterson, Andrew D.
    Rich, Stephen S.
    Hirschhorn, Joel N.
    Florez, Jose C.
    DIABETES, 2016, 65 : A100 - A100